Effect of pentoxifylline on preventing acute kidney injury after cardiac surgery by measuring urinary neutrophil gelatinase - associated lipocalin

Journal of Cardiothoracic Surgery

Volumn 6, Issue 1, 2011, Pages

  Barkhordari, Khosro ^a   Karimi, Abbasali ^a   Shafiee, Akbar ^b   Soltaninia, Hasan ^a   Khatami, Mohammad R ^a   Abbasi, Kiomars ^a   Yousefshahi, Fardin ^a   Haghighat, Babak ^a   Brown, Virginia ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Leyden Academy on Vitality and Ageing   (Netherlands)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PENTOXIFYLLINE; SCAVENGER;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; HUMANS; INJECTIONS, INTRAVENOUS; LIPOCALINS; MALE; MIDDLE AGED; PENTOXIFYLLINE; POSTOPERATIVE COMPLICATIONS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78651506794     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-8     Document Type: Article

References (24)

1. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245.
2. Haase M, Haase-Fielitz A, Bagshaw SM, Ronco C, Bellomo R. Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy?. Contrib Nephrol 2007, 156:340-353. full_text, 17464145.
3. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006, 1:19-32. 10.2215/CJN.00240605, 17699187.
4. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-8. 10.1016/S0140-6736(05)74811-X, 15811456.
5. Visser J, Groen H, Klatter F, Rozing J. Timing of pentoxifylline treatment determines its protective effect on diabetes development in the Bio Breeding rat. Eur J Pharmacol 2002, 445:133-40. 10.1016/S0014-2999(02)01625-4, 12065204.
6. Sullivan GW, Carper HT, Novick WJ, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 1988, 56:1722-9. 259468, 2838424.
7. Hammerman C, Goldschmidt D, Caplan MS, Kaplan M, Schimmel MS, Eidelman AI, Branski D, Hochman A. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Pediatr Gastroenterol Nutr 1999, 29:69-74. 10.1097/00005176-199907000-00017, 10400107.
8. Wu HM, Yuan QY, Zhou RL, Li J, Liu GJ. Pentoxifylline for diabetic kidney disease (Protocol). Cochrane Database of Systematic Reviews 2007, (4):CD006800.
9. Okumura AS, Rodrigues LE, Martinelli R. Pentoxifylline in ischemia-induced acute kidney injury in rats. Ren Fail 2009, 31:829-32. 10.3109/08860220903137509, 19925292.
10. Groesdonk HV, Bauer A, Kreft B, Heringlake M, Paarmann H, Pagel H. Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-induced acute renal failure in a model of isolated perfused rat kidney. Kidney Blood Press Res 2009, 32:81-90. 10.1159/000209378, 19321979.
11. Boldt J, Brosch C, Piper SN, Suttner S, Lehmann A, Werling C. Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 2001, 29:952-8. 10.1097/00003246-200105000-00008, 11378603.
12. Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, Campbell DA. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 2009, 110:505-15. 10.1097/ALN.0b013e3181979440, 19212261.
13. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury After Cardiac Surgery. Am J Kidney Dis 2008, 52:425-33. 10.1053/j.ajkd.2008.05.018, 18649981.
14. Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009, 53:261-6. 10.1097/FJC.0b013e31819d6139, 19247188.
15. Asimakopoulos G, Gourlay T. A review of anti-inflammatory strategies in cardiac surgery. Perfusion 2003, 18:7-12. 10.1191/0267659103pf623oa, 12708760.
16. Chong AJ, Hampton CR, Verrier ED. Microvascular Inflammatory Response in Cardiac Surgery Seminars in Cardiothoracic and Vascular. Anesthesia 2003, 7:333-54.
17. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002, 97:215-52. 10.1097/00000542-200207000-00030, 12131125.
18. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 2005, 59:302-6. 10.1016/j.biopha.2005.05.003, 15932791.
19. Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physio 2005, 289:H832-9.
20. Chapelier A, Reignier J, Mazmanian M, Detruit H, Dartevelle P, Parquin F, Cerrina J, Le Roy Ladurie F, Hervé P. Pentoxifylline and lung ischemia-reperfusion injury: application to lung transplantation. Université Paris-Sud Lung Transplant Group. J Cardiovasc Pharmacol 1995, 25(Suppl 2):S130-3. 10.1097/00005344-199500252-00027, 8699852.
21. Boldt J, Brosch C, Lehmann A, Haisch G, Lang J, Isgro F. Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Ann Thorac Surg 2001, 71:1524-9. 10.1016/S0003-4975(01)02462-6, 11383794.
22. Heinze H, Rosemann C, Weber C, Heinrichs G, Bahlmann L, Misfeld M, Heringlake M, Eichler W. A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery - a prospective randomized and controlled study. Eur J Cardiothorac Surg 2007, 32:83-9. 10.1016/j.ejcts.2007.04.011, 17499999.
23. Caǧ li K, Ulaş MM, Ozişik K, Kale A, Bakuy V, Emir M, Balci M, Topbaş M, Sener E, Taşdemir O. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 2005, 20:45-51.
24. Hemmer CJ, Hort G, Chiwakata CB, Seitz R, Egbring R, Gaus W, Hogel J, Hassemer M, Nawroth PP, Kern P, Dietrich M. Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg 1997, 56:397-403.